A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...

Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to ...

Efficacy outcomes included 15-year cumulative incidence of major adverse liver outcomes and decompensated cirrhosis. Key baseline variables such as type 2 diabetes, Fibrosis-4 score, and Ishak ...

No. 2 / 2025Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant ...

Although liver stiffness measured and enhanced liver fibrosis score declined in all groups, statistically significant differences between groups were not observed. Gilead and Novo are among a ...

Phuc Le, MD, discusses the growing prevalence of MASLD, emphasizing the need for early identification using non-invasive tools.

No. 2 / 2025Correction includes 2024 Annual Report attached in iXBRL format. Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant clinical ...